Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 0.2198
4.67 %
$ 6.16 M
Market Cap
-7.33
P/E
1. INTRINSIC VALUE
2. FUNDAMENTAL
ANALYSIS
Price Chart TTOO
FINANCIALS
Balance Sheet
T2 Biosystems, Inc.
| Current Assets | 25.2 M |
| Cash & Short-Term Investments | 15.7 M |
| Receivables | 1.42 M |
| Other Current Assets | 8.08 M |
| Non-Current Assets | 9.61 M |
| Long-Term Investments | 0 |
| PP&E | 9.05 M |
| Other Non-Current Assets | 555 K |
| Current Liabilities | 56.2 M |
| Accounts Payable | 1.53 M |
| Short-Term Debt | 42.9 M |
| Other Current Liabilities | 11.7 M |
| Non-Current Liabilities | 6.68 M |
| Long-Term Debt | 6.6 M |
| Other Non-Current Liabilities | 83 K |
EFFICIENCY
Earnings Waterfall
T2 Biosystems, Inc.
| Revenue | 7.19 M |
| Cost Of Revenue | 15.4 M |
| Gross Profit | -8.17 M |
| Operating Expenses | 41.5 M |
| Operating Income | -49.7 M |
| Other Expenses | 413 K |
| Net Income | -50.1 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
T2 Biosystems, Inc.
| Net Income | -50.1 M |
| Depreciation & Amortization | 859 K |
| Capital Expenditures | -192 K |
| Stock-Based Compensation | 4.35 M |
| Change in Working Capital | -4.04 M |
| Others | -3.5 M |
| Free Cash Flow | -48.3 M |
Wall Street Analysts Price Targets
T2 Biosystems, Inc.
Wall Street analysts predict an average 1-year price target for TTOO of $5 , with forecasts ranging from
a
low of
$5 to a high of $5 .
TTOO Lowest Price Target
Wall Street Target
5 USD
2174.80%
TTOO Average Price Target
Wall Street Target
5 USD
2174.80%
TTOO Highest Price Target
Wall Street Target
5 USD
2174.80%
4. DIVIDEND
ANALYSIS
TTOO does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
T2 Biosystems, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
133 USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
4 months ago
Sep 13, 2024
|
Sell 133
USD
|
Elsbree David B
Director
|
- 55
|
2.42 USD |
|
1 year ago
Feb 20, 2023
|
Sell 349
USD
|
Giffin Brett A.
Chief Commercial Officer
|
- 537
|
0.65 USD |
|
1 year ago
Sep 27, 2023
|
Sell 458 K
USD
|
CR Group L.P.
10 percent owner
|
- 2391981
|
0.1916 USD |
|
1 year ago
Sep 27, 2023
|
Sell 311 K
USD
|
CR Group L.P.
10 percent owner
|
- 1621313
|
0.1916 USD |
|
1 year ago
Sep 27, 2023
|
Sell 285 K
USD
|
CR Group L.P.
10 percent owner
|
- 1489512
|
0.1916 USD |
|
1 year ago
Sep 27, 2023
|
Sell 91.7 K
USD
|
CR Group L.P.
10 percent owner
|
- 478396
|
0.1916 USD |
|
1 year ago
Sep 28, 2023
|
Sell 305 K
USD
|
CR Group L.P.
10 percent owner
|
- 1937852
|
0.1575 USD |
|
1 year ago
Sep 26, 2023
|
Sell 433 K
USD
|
CR Group L.P.
10 percent owner
|
- 2156717
|
0.2007 USD |
|
1 year ago
Sep 26, 2023
|
Sell 293 K
USD
|
CR Group L.P.
10 percent owner
|
- 1461849
|
0.2007 USD |
|
1 year ago
Sep 26, 2023
|
Sell 270 K
USD
|
CR Group L.P.
10 percent owner
|
- 1343011
|
0.2007 USD |
|
1 year ago
Sep 26, 2023
|
Sell 86.6 K
USD
|
CR Group L.P.
10 percent owner
|
- 431343
|
0.2007 USD |
|
1 year ago
Sep 25, 2023
|
Sell 25 K
USD
|
CR Group L.P.
10 percent owner
|
- 99979
|
0.25 USD |
|
1 year ago
Sep 25, 2023
|
Sell 16.9 K
USD
|
CR Group L.P.
10 percent owner
|
- 67767
|
0.25 USD |
|
1 year ago
Sep 25, 2023
|
Sell 15.6 K
USD
|
CR Group L.P.
10 percent owner
|
- 62258
|
0.25 USD |
|
1 year ago
Sep 25, 2023
|
Sell 5 K
USD
|
CR Group L.P.
10 percent owner
|
- 19996
|
0.25 USD |
|
1 year ago
Sep 22, 2023
|
Sell 526 K
USD
|
CR Group L.P.
10 percent owner
|
- 2031313
|
0.2588 USD |
|
1 year ago
Sep 22, 2023
|
Sell 356 K
USD
|
CR Group L.P.
10 percent owner
|
- 1376848
|
0.2588 USD |
|
1 year ago
Sep 22, 2023
|
Sell 327 K
USD
|
CR Group L.P.
10 percent owner
|
- 1264920
|
0.2588 USD |
|
1 year ago
Sep 22, 2023
|
Sell 105 K
USD
|
CR Group L.P.
10 percent owner
|
- 406263
|
0.2588 USD |
|
1 year ago
Sep 21, 2023
|
Sell 762 K
USD
|
CR Group L.P.
10 percent owner
|
- 2534754
|
0.3005 USD |
|
1 year ago
Sep 21, 2023
|
Sell 516 K
USD
|
CR Group L.P.
10 percent owner
|
- 1718087
|
0.3005 USD |
|
1 year ago
Sep 21, 2023
|
Sell 474 K
USD
|
CR Group L.P.
10 percent owner
|
- 1578419
|
0.3005 USD |
|
1 year ago
Sep 21, 2023
|
Sell 152 K
USD
|
CR Group L.P.
10 percent owner
|
- 506951
|
0.3005 USD |
|
1 year ago
Sep 20, 2023
|
Sell 963 K
USD
|
CR Group L.P.
10 percent owner
|
- 3100836
|
0.3106 USD |
|
1 year ago
Sep 20, 2023
|
Sell 653 K
USD
|
CR Group L.P.
10 percent owner
|
- 2101784
|
0.3106 USD |
|
1 year ago
Sep 20, 2023
|
Sell 600 K
USD
|
CR Group L.P.
10 percent owner
|
- 1930923
|
0.3106 USD |
|
1 year ago
Sep 20, 2023
|
Sell 193 K
USD
|
CR Group L.P.
10 percent owner
|
- 620167
|
0.3106 USD |
|
1 year ago
Sep 19, 2023
|
Sell 1.52 M
USD
|
CR Group L.P.
10 percent owner
|
- 4159717
|
0.366 USD |
|
1 year ago
Sep 19, 2023
|
Sell 1.03 M
USD
|
CR Group L.P.
10 percent owner
|
- 2819506
|
0.366 USD |
|
1 year ago
Sep 19, 2023
|
Sell 948 K
USD
|
CR Group L.P.
10 percent owner
|
- 2590300
|
0.366 USD |
|
1 year ago
Sep 19, 2023
|
Sell 304 K
USD
|
CR Group L.P.
10 percent owner
|
- 831943
|
0.366 USD |
|
1 year ago
Mar 28, 2023
|
Sell 115
USD
|
Gibbs Michael Terrence
General Counsel
|
- 239
|
0.481 USD |
|
1 year ago
Feb 22, 2023
|
Sell 349
USD
|
Giffin Brett A.
Chief Commercial Officer
|
- 537
|
0.65 USD |
|
1 year ago
Feb 28, 2023
|
Sell 677
USD
|
Sprague John M
Chief Financial Officer
|
- 1148
|
0.59 USD |
|
1 year ago
Feb 22, 2023
|
Sell 1 K
USD
|
Sprague John M
Chief Financial Officer
|
- 1545
|
0.65 USD |
|
1 year ago
Feb 28, 2023
|
Sell 935
USD
|
Gibbs Michael Terrence
General Counsel
|
- 1585
|
0.59 USD |
|
1 year ago
Feb 22, 2023
|
Sell 1.39 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 2145
|
0.65 USD |
|
1 year ago
Feb 28, 2023
|
Sell 1.71 K
USD
|
Sperzel John J III
Chairman and CEO
|
- 2898
|
0.59 USD |
|
1 year ago
Feb 22, 2023
|
Sell 4.47 K
USD
|
Sperzel John J III
Chairman and CEO
|
- 6875
|
0.65 USD |
|
2 years ago
Nov 10, 2022
|
Sell 2.32 K
USD
|
Giffin Brett A.
Chief Commercial Officer
|
- 1292
|
1.793 USD |
|
2 years ago
Apr 07, 2022
|
Bought
15 K USD
|
Sperzel John J III
Chairman, CEO, and President
|
+ 30000
|
0.5 USD |
|
2 years ago
Apr 08, 2022
|
Bought
6.48 K USD
|
Barclay Alec
Chief Operations Officer
|
+ 12951.88
|
0.5 USD |
|
2 years ago
Apr 07, 2022
|
Bought
4.9 K USD
|
Gibbs Michael Terrence
General Counsel
|
+ 10000
|
0.49 USD |
|
2 years ago
Apr 08, 2022
|
Bought
4.77 K USD
|
Sprague John M
Chief Financial Officer
|
+ 10000
|
0.4767 USD |
|
2 years ago
Apr 08, 2022
|
Bought
5.18 K USD
|
Giffin Brett A.
Chief Commercial Officer
|
+ 10600
|
0.489 USD |
|
3 years ago
Jan 06, 2022
|
Sell 29.8 K
USD
|
Ahuja Aparna
Chief Medical Officer
|
- 61988
|
0.48 USD |
|
4 years ago
May 06, 2020
|
Bought
14.5 K USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 26200
|
0.5517 USD |
|
4 years ago
May 20, 2020
|
Bought
4.12 K USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 5126
|
0.803 USD |
|
4 years ago
May 06, 2020
|
Sell 5.76 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 10100
|
0.57 USD |
|
4 years ago
May 19, 2020
|
Bought
8.6 K USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 10328
|
0.8329 USD |
|
4 years ago
May 12, 2020
|
Bought
1.36 K USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 2500
|
0.546 USD |
|
4 years ago
May 19, 2020
|
Sell 668
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 800
|
0.8345 USD |
|
4 years ago
May 06, 2020
|
Sell 1.14 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 2000
|
0.5701 USD |
|
4 years ago
Apr 09, 2020
|
Bought
490 USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 1000
|
0.49 USD |
|
4 years ago
Mar 25, 2020
|
Bought
557 USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 600
|
0.9279 USD |
|
4 years ago
Mar 24, 2020
|
Bought
189 USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
+ 500
|
0.378 USD |
|
4 years ago
May 06, 2020
|
Sell 570
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 1000
|
0.5702 USD |
|
4 years ago
Mar 24, 2020
|
Sell 189
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 500
|
0.378 USD |
|
4 years ago
Mar 25, 2020
|
Sell 557
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 600
|
0.9279 USD |
|
4 years ago
Apr 09, 2020
|
Sell 490
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 1000
|
0.49 USD |
|
4 years ago
May 12, 2020
|
Sell 1.36 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 2500
|
0.546 USD |
|
4 years ago
May 19, 2020
|
Sell 1.7 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 2031
|
0.8347 USD |
|
4 years ago
May 19, 2020
|
Sell 166
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 200
|
0.8314 USD |
|
4 years ago
May 06, 2020
|
Sell 1.38 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 2655
|
0.52 USD |
|
4 years ago
May 19, 2020
|
Sell 2.69 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 3235
|
0.8318 USD |
|
4 years ago
May 06, 2020
|
Sell 521
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 1000
|
0.521 USD |
|
4 years ago
May 06, 2020
|
Sell 526
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 1000
|
0.526 USD |
|
4 years ago
May 06, 2020
|
Sell 264
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 500
|
0.528 USD |
|
4 years ago
May 06, 2020
|
Sell 26.5
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 50
|
0.53 USD |
|
4 years ago
May 19, 2020
|
Sell 1.69 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 2031
|
0.8325 USD |
|
4 years ago
May 06, 2020
|
Sell 266
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 500
|
0.5318 USD |
|
4 years ago
May 06, 2020
|
Sell 53.2
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 100
|
0.5325 USD |
|
4 years ago
May 19, 2020
|
Sell 1.69 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 2031
|
0.8326 USD |
|
4 years ago
May 06, 2020
|
Sell 3.38 K
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 6256
|
0.54 USD |
|
4 years ago
May 06, 2020
|
Sell 55
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 100
|
0.55 USD |
|
4 years ago
May 06, 2020
|
Sell 517
USD
|
GOLDMAN SACHS & CO. LLC
10 percent owner
|
- 939
|
0.5503 USD |
|
4 years ago
May 06, 2020
|
Bought
14.5 K USD
|
Jones Adrian M
Director
|
+ 26200
|
0.5517 USD |
|
4 years ago
May 20, 2020
|
Bought
4.12 K USD
|
Jones Adrian M
Director
|
+ 5126
|
0.803 USD |
|
4 years ago
May 06, 2020
|
Sell 5.76 K
USD
|
Jones Adrian M
Director
|
- 10100
|
0.57 USD |
|
4 years ago
May 19, 2020
|
Bought
8.6 K USD
|
Jones Adrian M
Director
|
+ 10328
|
0.8329 USD |
|
4 years ago
May 12, 2020
|
Bought
1.36 K USD
|
Jones Adrian M
Director
|
+ 2500
|
0.546 USD |
|
4 years ago
May 19, 2020
|
Sell 668
USD
|
Jones Adrian M
Director
|
- 800
|
0.8345 USD |
|
4 years ago
Apr 09, 2020
|
Bought
490 USD
|
Jones Adrian M
Director
|
+ 1000
|
0.49 USD |
|
4 years ago
May 06, 2020
|
Sell 1.14 K
USD
|
Jones Adrian M
Director
|
- 2000
|
0.5701 USD |
|
4 years ago
Mar 25, 2020
|
Bought
557 USD
|
Jones Adrian M
Director
|
+ 600
|
0.9279 USD |
|
4 years ago
Mar 24, 2020
|
Bought
189 USD
|
Jones Adrian M
Director
|
+ 500
|
0.378 USD |
|
4 years ago
Mar 25, 2020
|
Sell 557
USD
|
Jones Adrian M
Director
|
- 600
|
0.9279 USD |
|
4 years ago
Mar 24, 2020
|
Sell 189
USD
|
Jones Adrian M
Director
|
- 500
|
0.378 USD |
|
4 years ago
May 19, 2020
|
Sell 1.7 K
USD
|
Jones Adrian M
Director
|
- 2031
|
0.8347 USD |
|
4 years ago
May 06, 2020
|
Sell 570
USD
|
Jones Adrian M
Director
|
- 1000
|
0.5702 USD |
|
4 years ago
Apr 09, 2020
|
Sell 490
USD
|
Jones Adrian M
Director
|
- 1000
|
0.49 USD |
|
4 years ago
May 12, 2020
|
Sell 1.36 K
USD
|
Jones Adrian M
Director
|
- 2500
|
0.546 USD |
|
4 years ago
May 19, 2020
|
Sell 166
USD
|
Jones Adrian M
Director
|
- 200
|
0.8314 USD |
|
4 years ago
May 06, 2020
|
Sell 1.38 K
USD
|
Jones Adrian M
Director
|
- 2655
|
0.52 USD |
|
4 years ago
May 19, 2020
|
Sell 2.69 K
USD
|
Jones Adrian M
Director
|
- 3235
|
0.8318 USD |
|
4 years ago
May 06, 2020
|
Sell 521
USD
|
Jones Adrian M
Director
|
- 1000
|
0.521 USD |
|
4 years ago
May 06, 2020
|
Sell 526
USD
|
Jones Adrian M
Director
|
- 1000
|
0.526 USD |
|
4 years ago
May 06, 2020
|
Sell 264
USD
|
Jones Adrian M
Director
|
- 500
|
0.528 USD |
|
4 years ago
May 06, 2020
|
Sell 26.5
USD
|
Jones Adrian M
Director
|
- 50
|
0.53 USD |
|
4 years ago
May 19, 2020
|
Sell 1.69 K
USD
|
Jones Adrian M
Director
|
- 2031
|
0.8325 USD |
|
4 years ago
May 06, 2020
|
Sell 266
USD
|
Jones Adrian M
Director
|
- 500
|
0.5318 USD |
|
4 years ago
May 06, 2020
|
Sell 53.2
USD
|
Jones Adrian M
Director
|
- 100
|
0.5325 USD |
|
4 years ago
May 19, 2020
|
Sell 1.69 K
USD
|
Jones Adrian M
Director
|
- 2031
|
0.8326 USD |
|
4 years ago
May 06, 2020
|
Sell 3.38 K
USD
|
Jones Adrian M
Director
|
- 6256
|
0.54 USD |
|
4 years ago
May 06, 2020
|
Sell 55
USD
|
Jones Adrian M
Director
|
- 100
|
0.55 USD |
|
4 years ago
May 06, 2020
|
Sell 517
USD
|
Jones Adrian M
Director
|
- 939
|
0.5503 USD |
|
3 years ago
Jul 01, 2021
|
Sell 21.1 K
USD
|
McDonough John
Director
|
- 18182
|
1.16 USD |
|
3 years ago
Jul 01, 2021
|
Sell 21.1 K
USD
|
CUMMING JOHN W
Director
|
- 18182
|
1.16 USD |
|
3 years ago
Mar 25, 2021
|
Sell 13.7 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 8758
|
1.56 USD |
|
3 years ago
Mar 17, 2021
|
Sell 23.2 K
USD
|
Barclay Alec
Chief Operations Officer
|
- 12494
|
1.86 USD |
|
3 years ago
Mar 17, 2021
|
Sell 17.7 K
USD
|
Pare Anthony
Chief Commercial Officer
|
- 9620
|
1.84 USD |
|
3 years ago
Feb 23, 2021
|
Sell 15 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 7280
|
2.06 USD |
|
3 years ago
Feb 23, 2021
|
Sell 10.7 K
USD
|
Sprague John M
Chief Financial Officer
|
- 5250
|
2.04 USD |
|
3 years ago
Feb 23, 2021
|
Sell 15 K
USD
|
Barclay Alec
Chief Operations Officer
|
- 7280
|
2.06 USD |
|
4 years ago
Feb 24, 2020
|
Sell 3.42 K
USD
|
Sprague John M
Chief Financial Officer
|
- 4166
|
0.82 USD |
|
4 years ago
Feb 24, 2020
|
Sell 4.76 K
USD
|
Barclay Alec
SVP, Operations
|
- 5808
|
0.82 USD |
|
4 years ago
Feb 24, 2020
|
Sell 4.76 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 5808
|
0.82 USD |
|
4 years ago
Feb 24, 2020
|
Sell 4.76 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 5808
|
0.82 USD |
|
4 years ago
Feb 11, 2020
|
Sell 2.46 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 3200
|
0.77 USD |
|
4 years ago
Feb 11, 2020
|
Sell 2.46 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 3200
|
0.77 USD |
|
4 years ago
Feb 03, 2020
|
Sell 2.89 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 3283
|
0.88 USD |
|
4 years ago
Feb 03, 2020
|
Sell 20.9 K
USD
|
McDonough John
Director
|
- 23754
|
0.88 USD |
|
4 years ago
Feb 03, 2020
|
Sell 6.63 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 7535
|
0.88 USD |
|
5 years ago
Jan 23, 2020
|
Sell 66 K
USD
|
McDonough John
Director
|
- 57417
|
1.15 USD |
|
5 years ago
Jan 03, 2020
|
Sell 6.17 K
USD
|
Elsbree David B
Director
|
- 5316
|
1.16 USD |
|
5 years ago
Sep 11, 2019
|
Sell 12.3 K
USD
|
Barclay Alec
SVP, Operations
|
- 4210
|
2.92 USD |
|
5 years ago
Jun 11, 2019
|
Sell 4.63 K
USD
|
Cima Michael J.
Director
|
- 3240
|
1.43 USD |
|
5 years ago
Jun 11, 2019
|
Sell 13 K
USD
|
Lapidus Stanley
Director
|
- 9000
|
1.44 USD |
|
5 years ago
Jun 11, 2019
|
Sell 4.89 K
USD
|
CUMMING JOHN W
Director
|
- 3420
|
1.43 USD |
|
5 years ago
Jun 11, 2019
|
Sell 5.18 K
USD
|
Elsbree David B
Director
|
- 3600
|
1.44 USD |
|
5 years ago
Feb 11, 2019
|
Sell 10.1 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 3005
|
3.36 USD |
|
5 years ago
Feb 11, 2019
|
Sell 10.1 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 3005
|
3.36 USD |
|
5 years ago
Feb 11, 2019
|
Sell 27.3 K
USD
|
McDonough John
President & CEO
|
- 8134
|
3.36 USD |
|
6 years ago
Jan 31, 2019
|
Sell 3.15 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 939
|
3.35 USD |
|
6 years ago
Feb 01, 2019
|
Sell 6.32 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 1820
|
3.47 USD |
|
6 years ago
Jan 31, 2019
|
Sell 16.4 K
USD
|
McDonough John
President & CEO
|
- 4895
|
3.35 USD |
|
6 years ago
Feb 01, 2019
|
Sell 32.8 K
USD
|
McDonough John
President & CEO
|
- 9443
|
3.47 USD |
|
6 years ago
Jan 31, 2019
|
Sell 7.26 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 2166
|
3.35 USD |
|
6 years ago
Feb 01, 2019
|
Sell 14.5 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 4185
|
3.47 USD |
|
6 years ago
Nov 06, 2018
|
Sell 32 K
USD
|
Lapidus Stanley
Director
|
- 6048
|
5.29 USD |
|
6 years ago
Sep 20, 2018
|
Sell 298 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 48205
|
6.18 USD |
|
6 years ago
Sep 18, 2018
|
Sell 89.9 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 14647
|
6.14 USD |
|
6 years ago
Sep 18, 2018
|
Sell 528 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 85595
|
6.17 USD |
|
6 years ago
Sep 19, 2018
|
Sell 235 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 37902
|
6.2 USD |
|
6 years ago
Feb 09, 2018
|
Sell 26.9 K
USD
|
McDonough John
President & CEO
|
- 6292
|
4.28 USD |
|
6 years ago
Feb 09, 2018
|
Sell 9.42 K
USD
|
Gibbs Michael Terrence
General Counsel
|
- 2202
|
4.28 USD |
|
6 years ago
Feb 09, 2018
|
Sell 9.42 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 2202
|
4.28 USD |
|
6 years ago
Jun 01, 2018
|
Bought
32.3 K USD
|
Elsbree David B
Director
|
+ 4225
|
7.65 USD |
|
6 years ago
Jun 05, 2018
|
Sell 53.2 K
USD
|
Lapidus Stanley
Director
|
- 6000
|
8.87 USD |
|
7 years ago
Nov 16, 2017
|
Bought
6.17 K USD
|
Elsbree David B
Director
|
+ 1500
|
4.11 USD |
|
7 years ago
Jun 06, 2017
|
Bought
3.5 K USD
|
Dhanda Rahul
SVP of Corporate Development
|
+ 1000
|
3.5 USD |
|
7 years ago
Jun 06, 2017
|
Bought
17.5 K USD
|
Spadoro Joanne
Chief Operations Officer
|
+ 5000
|
3.5 USD |
|
7 years ago
Jun 06, 2017
|
Bought
3.51 K USD
|
Gibbs Michael Terrence
General Counsel
|
+ 1000
|
3.51 USD |
|
7 years ago
Jun 06, 2017
|
Bought
35 K USD
|
Elsbree David B
Director
|
+ 10000
|
3.5 USD |
|
7 years ago
Jun 06, 2017
|
Bought
14.3 K USD
|
DEPTULA-HICKS DARLENE M
SVP & Chief Financial Officer
|
+ 4000
|
3.58 USD |
|
7 years ago
May 05, 2017
|
Bought
5.29 K USD
|
Cima Michael J.
Director
|
+ 1400
|
3.78 USD |
|
7 years ago
Mar 15, 2017
|
Bought
59.7 K USD
|
Elsbree David B
Director
|
+ 10000
|
5.97 USD |
|
8 years ago
Jun 30, 2016
|
Sell 29.3 K
USD
|
Dhanda Rahul
SVP of Corporate Development
|
- 3589
|
8.16 USD |
|
8 years ago
Mar 16, 2016
|
Sell 37.2 K
USD
|
Dhanda Rahul
SVP of Corporate Development
|
- 4647
|
8 USD |
|
8 years ago
Mar 16, 2016
|
Sell 23.6 K
USD
|
Dhanda Rahul
SVP of Corporate Development
|
- 2941
|
8.03 USD |
|
8 years ago
Mar 15, 2016
|
Sell 114 K
USD
|
Dhanda Rahul
SVP of Corporate Development
|
- 13770
|
8.29 USD |
|
8 years ago
Mar 14, 2016
|
Sell 23.8 K
USD
|
Dhanda Rahul
SVP of Corporate Development
|
- 2700
|
8.823 USD |
|
9 years ago
Dec 09, 2015
|
Bought
6.82 M USD
|
CARELLA THOMAS J.
Director
|
+ 700000
|
9.75 USD |
|
9 years ago
Dec 09, 2015
|
Bought
6.82 M USD
|
MBD Advisors, L.L.C.
10 percent owner
|
+ 700000
|
9.75 USD |
|
9 years ago
Dec 09, 2015
|
Bought
6.82 M USD
|
GOLDMAN SACHS GROUP INC
10 percent owner
|
+ 700000
|
9.75 USD |
|
9 years ago
Dec 09, 2015
|
Bought
97.5 K USD
|
Elsbree David B
Director
|
+ 10000
|
9.75 USD |
|
9 years ago
Dec 09, 2015
|
Bought
3 M USD
|
AISLING CAPITAL III LP
10 percent owner
|
+ 307692
|
9.75 USD |
|
9 years ago
Aug 07, 2015
|
Bought
14 K USD
|
Cima Michael J.
Director
|
+ 1000
|
14.01 USD |
|
9 years ago
Aug 07, 2015
|
Bought
982 USD
|
Elsbree David B
Director
|
+ 75
|
13.0899 USD |
|
9 years ago
Aug 05, 2015
|
Sell 156 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 10367
|
15.0201 USD |
|
9 years ago
Aug 05, 2015
|
Sell 1.56 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 104
|
15.0201 USD |
|
9 years ago
Aug 05, 2015
|
Sell 1.07 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 71
|
15.0201 USD |
|
9 years ago
Aug 05, 2015
|
Sell 3.03 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 202
|
15.0201 USD |
|
9 years ago
Jul 23, 2015
|
Sell 218 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.0426 USD |
|
9 years ago
Jul 24, 2015
|
Sell 5.78 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 385
|
15 USD |
|
9 years ago
Jul 23, 2015
|
Sell 2.17 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.0426 USD |
|
9 years ago
Jul 24, 2015
|
Sell 60
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 4
|
15 USD |
|
9 years ago
Jul 23, 2015
|
Sell 1.49 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.0426 USD |
|
9 years ago
Jul 24, 2015
|
Sell 45
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 3
|
15 USD |
|
9 years ago
Jul 23, 2015
|
Sell 4.24 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.0426 USD |
|
9 years ago
Jul 24, 2015
|
Sell 120
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 8
|
15 USD |
|
9 years ago
Jul 20, 2015
|
Sell 232 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.0522 USD |
|
9 years ago
Jul 21, 2015
|
Sell 223 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.4209 USD |
|
9 years ago
Jul 22, 2015
|
Sell 220 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.2243 USD |
|
9 years ago
Jul 20, 2015
|
Sell 2.31 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.0522 USD |
|
9 years ago
Jul 21, 2015
|
Sell 2.22 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.4209 USD |
|
9 years ago
Jul 22, 2015
|
Sell 2.19 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.2243 USD |
|
9 years ago
Jul 20, 2015
|
Sell 1.59 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.0522 USD |
|
9 years ago
Jul 21, 2015
|
Sell 1.53 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.4209 USD |
|
9 years ago
Jul 22, 2015
|
Sell 1.51 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.2243 USD |
|
9 years ago
Jul 20, 2015
|
Sell 4.53 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.0522 USD |
|
9 years ago
Jul 21, 2015
|
Sell 4.35 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.4209 USD |
|
9 years ago
Jul 22, 2015
|
Sell 4.29 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.2243 USD |
|
9 years ago
Jul 15, 2015
|
Sell 234 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.1437 USD |
|
9 years ago
Jul 16, 2015
|
Sell 236 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.3316 USD |
|
9 years ago
Jul 17, 2015
|
Sell 236 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.2978 USD |
|
9 years ago
Jul 15, 2015
|
Sell 2.32 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.1437 USD |
|
9 years ago
Jul 16, 2015
|
Sell 2.35 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.3316 USD |
|
9 years ago
Jul 17, 2015
|
Sell 2.35 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.2978 USD |
|
9 years ago
Jul 15, 2015
|
Sell 1.6 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.1437 USD |
|
9 years ago
Jul 16, 2015
|
Sell 1.62 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.3316 USD |
|
9 years ago
Jul 17, 2015
|
Sell 1.61 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.2978 USD |
|
9 years ago
Jul 15, 2015
|
Sell 4.55 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.1437 USD |
|
9 years ago
Jul 16, 2015
|
Sell 4.61 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.3316 USD |
|
9 years ago
Jul 17, 2015
|
Sell 4.6 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.2978 USD |
|
9 years ago
Jul 13, 2015
|
Sell 240 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.5957 USD |
|
9 years ago
Jul 14, 2015
|
Sell 239 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.5413 USD |
|
9 years ago
Jul 13, 2015
|
Sell 2.39 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.5957 USD |
|
9 years ago
Jul 14, 2015
|
Sell 2.38 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.5413 USD |
|
9 years ago
Jul 13, 2015
|
Sell 1.64 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.5957 USD |
|
9 years ago
Jul 14, 2015
|
Sell 1.64 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.5413 USD |
|
9 years ago
Jul 13, 2015
|
Sell 4.68 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.5957 USD |
|
9 years ago
Jul 14, 2015
|
Sell 4.66 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.5413 USD |
|
9 years ago
Jul 10, 2015
|
Sell 32.1 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 2000
|
16.03 USD |
|
9 years ago
Jul 08, 2015
|
Sell 232 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.9949 USD |
|
9 years ago
Jul 09, 2015
|
Sell 233 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.1239 USD |
|
9 years ago
Jul 10, 2015
|
Sell 241 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.6255 USD |
|
9 years ago
Jul 08, 2015
|
Sell 2.3 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.9949 USD |
|
9 years ago
Jul 09, 2015
|
Sell 2.32 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.1239 USD |
|
9 years ago
Jul 10, 2015
|
Sell 2.39 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.6255 USD |
|
9 years ago
Jul 08, 2015
|
Sell 1.58 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.9949 USD |
|
9 years ago
Jul 09, 2015
|
Sell 1.6 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.1239 USD |
|
9 years ago
Jul 10, 2015
|
Sell 1.65 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.6255 USD |
|
9 years ago
Jul 08, 2015
|
Sell 4.51 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.9949 USD |
|
9 years ago
Jul 09, 2015
|
Sell 4.55 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.1239 USD |
|
9 years ago
Jul 10, 2015
|
Sell 4.69 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.6255 USD |
|
9 years ago
Jul 02, 2015
|
Sell 224 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 14474
|
15.5053 USD |
|
9 years ago
Jul 02, 2015
|
Sell 224 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.5053 USD |
|
9 years ago
Jul 06, 2015
|
Sell 231 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 14474
|
15.9807 USD |
|
9 years ago
Jul 06, 2015
|
Sell 231 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.9807 USD |
|
9 years ago
Jul 07, 2015
|
Sell 235 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 14474
|
16.23 USD |
|
9 years ago
Jul 07, 2015
|
Sell 235 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.23 USD |
|
9 years ago
Jul 02, 2015
|
Sell 2.23 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.5053 USD |
|
9 years ago
Jul 02, 2015
|
Sell 2.23 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 144
|
15.5053 USD |
|
9 years ago
Jul 06, 2015
|
Sell 2.3 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 144
|
15.9807 USD |
|
9 years ago
Jul 06, 2015
|
Sell 2.3 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.9807 USD |
|
9 years ago
Jul 07, 2015
|
Sell 2.34 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 144
|
16.23 USD |
|
9 years ago
Jul 07, 2015
|
Sell 2.34 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.23 USD |
|
9 years ago
Jul 02, 2015
|
Sell 1.54 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 99
|
15.5053 USD |
|
9 years ago
Jul 02, 2015
|
Sell 1.54 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.5053 USD |
|
9 years ago
Jul 06, 2015
|
Sell 1.58 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.9807 USD |
|
9 years ago
Jul 06, 2015
|
Sell 1.58 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 99
|
15.9807 USD |
|
9 years ago
Jul 07, 2015
|
Sell 1.61 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.23 USD |
|
9 years ago
Jul 07, 2015
|
Sell 1.61 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 99
|
16.23 USD |
|
9 years ago
Jul 02, 2015
|
Sell 4.37 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.5053 USD |
|
9 years ago
Jul 02, 2015
|
Sell 4.37 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 282
|
15.5053 USD |
|
9 years ago
Jul 06, 2015
|
Sell 4.51 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.9807 USD |
|
9 years ago
Jul 06, 2015
|
Sell 4.51 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 282
|
15.9807 USD |
|
9 years ago
Jul 07, 2015
|
Sell 4.58 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.23 USD |
|
9 years ago
Jul 07, 2015
|
Sell 4.58 K
USD
|
Polaris Venture Partners V, L.P.
Director
|
- 282
|
16.23 USD |
|
9 years ago
Jun 29, 2015
|
Sell 236 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.2768 USD |
|
9 years ago
Jun 30, 2015
|
Sell 235 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.2157 USD |
|
9 years ago
Jul 01, 2015
|
Sell 228 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
15.7728 USD |
|
9 years ago
Jun 29, 2015
|
Sell 2.34 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.2768 USD |
|
9 years ago
Jun 30, 2015
|
Sell 2.34 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.2157 USD |
|
9 years ago
Jul 01, 2015
|
Sell 2.27 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
15.7728 USD |
|
9 years ago
Jun 29, 2015
|
Sell 1.61 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.2768 USD |
|
9 years ago
Jun 30, 2015
|
Sell 1.61 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.2157 USD |
|
9 years ago
Jul 01, 2015
|
Sell 1.56 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
15.7728 USD |
|
9 years ago
Jun 29, 2015
|
Sell 4.59 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.2768 USD |
|
9 years ago
Jun 30, 2015
|
Sell 4.57 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.2157 USD |
|
9 years ago
Jul 01, 2015
|
Sell 4.45 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
15.7728 USD |
|
9 years ago
Jun 24, 2015
|
Sell 255 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
17.6129 USD |
|
9 years ago
Jun 25, 2015
|
Sell 244 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.8531 USD |
|
9 years ago
Jun 26, 2015
|
Sell 243 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
16.7607 USD |
|
9 years ago
Jun 24, 2015
|
Sell 2.54 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
17.6129 USD |
|
9 years ago
Jun 25, 2015
|
Sell 2.43 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.8531 USD |
|
9 years ago
Jun 26, 2015
|
Sell 2.41 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
16.7607 USD |
|
9 years ago
Jun 24, 2015
|
Sell 1.74 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
17.6129 USD |
|
9 years ago
Jun 25, 2015
|
Sell 1.67 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.8531 USD |
|
9 years ago
Jun 26, 2015
|
Sell 1.66 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
16.7607 USD |
|
9 years ago
Jun 24, 2015
|
Sell 4.97 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
17.6129 USD |
|
9 years ago
Jun 25, 2015
|
Sell 4.75 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.8531 USD |
|
9 years ago
Jun 26, 2015
|
Sell 4.73 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
16.7607 USD |
|
9 years ago
Jun 22, 2015
|
Sell 264 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
18.2169 USD |
|
9 years ago
Jun 23, 2015
|
Sell 263 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 14474
|
18.1473 USD |
|
9 years ago
Jun 22, 2015
|
Sell 2.62 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
18.2169 USD |
|
9 years ago
Jun 23, 2015
|
Sell 2.61 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 144
|
18.1473 USD |
|
9 years ago
Jun 22, 2015
|
Sell 1.8 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
18.2169 USD |
|
9 years ago
Jun 23, 2015
|
Sell 1.8 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 99
|
18.1473 USD |
|
9 years ago
Jun 22, 2015
|
Sell 5.14 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
18.2169 USD |
|
9 years ago
Jun 23, 2015
|
Sell 5.12 K
USD
|
Polaris Venture Partners V, L.P.
10 percent owner
|
- 282
|
18.1473 USD |
|
9 years ago
Jun 18, 2015
|
Sell 18.6 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 1000
|
18.65 USD |
|
9 years ago
Jun 12, 2015
|
Bought
18.9 K USD
|
Cima Michael J.
Director
|
+ 1000
|
18.91 USD |
|
9 years ago
Jun 12, 2015
|
Sell 27.3 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 1471
|
18.55 USD |
|
9 years ago
Jun 02, 2015
|
Sell 15.5 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 882
|
17.52 USD |
|
9 years ago
May 20, 2015
|
Sell 16 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 1000
|
16.04 USD |
|
9 years ago
May 19, 2015
|
Bought
98.8 K USD
|
Elsbree David B
Director
|
+ 6000
|
16.47 USD |
|
9 years ago
May 19, 2015
|
Bought
4.12 K USD
|
Elsbree David B
Director
|
+ 250
|
16.48 USD |
|
9 years ago
May 04, 2015
|
Sell 16 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 1000
|
16 USD |
|
9 years ago
May 08, 2015
|
Sell 252 K
USD
|
Pfaller Michael A.
Chief Medical Officer
|
- 15440
|
16.31 USD |
|
10 years ago
Aug 12, 2014
|
Bought
55 K USD
|
Kalil Sarah O.
Chief Operating Officer
|
+ 5000
|
11 USD |
|
9 years ago
Apr 20, 2015
|
Sell 18.4 K
USD
|
Lowery Thomas J.
Chief Scientific Officer
|
- 1000
|
18.426 USD |
|
9 years ago
Mar 04, 2015
|
Bought
21.8 K USD
|
Elsbree David B
Director
|
+ 1450
|
15.05 USD |
|
10 years ago
Nov 13, 2014
|
Bought
22.1 K USD
|
Elsbree David B
Director
|
+ 1500
|
14.75 USD |
|
10 years ago
Aug 12, 2014
|
Bought
10 M USD
|
MBD Advisors, L.L.C.
10 percent owner
|
+ 909090
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
10 M USD
|
GOLDMAN SACHS GROUP INC
10 percent owner
|
+ 909090
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
10 M USD
|
CARELLA THOMAS J.
Director
|
+ 909090
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
5 M USD
|
AISLING CAPITAL III LP
10 percent owner
|
+ 454545
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
22 K USD
|
Cima Michael J.
Director
|
+ 2000
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
165 K USD
|
Elsbree David B
Director
|
+ 15000
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
165 K USD
|
Kalil Sarah O.
Chief Operating Officer
|
+ 15000
|
11 USD |
|
10 years ago
Aug 12, 2014
|
Bought
330 K USD
|
Crane Alan L
Director
|
+ 30000
|
11 USD |
7. News
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier agreement with Vizient, Inc., the largest member-driven health care performance improvement company in the United States, has been extended through March 31, 2026. The products covered under the contract with Vizient include the T2Dx® Instrument, the T2Bacteria® Panel and the T2Candida® Panel, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood.
globenewswire.com
- 1 month ago
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream
globenewswire.com
- 1 month ago
T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript
T2 Biosystems, Inc. (NASDAQ:TTOO ) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Trip Taylor - Investor Relations John Sperzel - Chairman & Chief Executive Officer John Sprague - Chief Financial Officer Conference Call Participants Yi Chen - H.C. Wainwright Operator Greetings.
seekingalpha.com
- 2 months ago
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the third quarter 2024 and business updates after market close on Thursday, November 14, 2024.
globenewswire.com
- 2 months ago
T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript
T2 Biosystems, Inc. (NASDAQ:TTOO ) Business Update Conference Call October 10, 2024 4:30 PM ET Company Participants Trip Taylor - IR John Sperzel - Chairman and CEO Conference Call Participants Eduardo Martinez - H.C. Wainwright Operator Good day, everyone.
seekingalpha.com
- 3 months ago
T2 Biosystems to Host Business Update Call on October 10, 2024
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will host a business update call to provide additional details on recent developments after market close at 4:30pm ET on Thursday October 10, 2024. On the call management also plans to address select questions from shareholders that can be submitted in advance to the investor relations team at ir@T2Biosystems.com .
globenewswire.com
- 3 months ago
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has entered into a multi-year exclusive U.S. agreement with Cardinal Health (NYSE: CAH),. Under the agreement, Cardinal Health will have exclusive rights to sell T2 Biosystems' FDA-cleared direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens, including the T2Dx® Instrument, the T2Bacteria® Panel, and the T2Candida® Panel.
globenewswire.com
- 3 months ago
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has successfully defended against an opposition filed against a key patent for its direct-from-whole blood detection method in the European Union.
globenewswire.com
- 4 months ago
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright 26th Annual Global Investment Conference.
globenewswire.com
- 5 months ago
T2 Biosystems to Attend Upcoming Investor Conferences
LEXINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in two upcoming investor conferences in August 2024:
globenewswire.com
- 6 months ago
T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript
T2 Biosystems, Inc. (NASDAQ:TTOO ) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Trip Taylor - Investor Relations John Sperzel - Chairman & Chief Executive Officer John Sprague - Chief Financial Officer Conference Call Participants Kyle Mikson - Canaccord Operator Greetings, and welcome to T2 Biosystems, Inc. Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
seekingalpha.com
- 6 months ago
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Malaysia and Indonesia. Under the terms of the agreement, T2 Biosystems will sell the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, and the T2Resistance® Panel through the newly appointed distributor.
globenewswire.com
- 6 months ago
8. Profile
Summary
T2 Biosystems, Inc. TTOO
COUNTRY
US
INDUSTRY
Medical - Diagnostics & Research
MARKET CAP
$ 6.16 M
Dividend Yield
0.00%
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Contact
101 Hartwell Avenue, Lexington, MA, 02421
https://www.t2biosystems.com
IPO
Date
Aug. 7, 2014
Employees
113
Officers
Mr. Michael Terrence Gibbs Esq.
Senior Vice President, General Counsel & Company Secretary
Mr. John M. Sprague CPA
Chief Financial Officer
Mr. John J. Sperzel III, B.Sc.
President, Chief Executive Officer & Chairman
Dr. Roger Smith Ph.D.
Senior Vice President of Science Research & Development
Ms. Kelley J. Morgan
Chief People Officer
Mr. Brett A. Giffin
Chief Commercial Officer